KPTI - Karyopharm Therapeutics Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts8288
Avg. Estimate-0.68-0.33-3.15-1.87
Low Estimate-0.82-0.59-3.31-3.2
High Estimate-0.61-0.07-3.07-0.33
Year Ago EPS-0.96-1.09-3.14-3.15
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts8288
Avg. Estimate15.65M42.92M38.35M129.97M
Low Estimate12M17.64M34M60.32M
High Estimate19.3M68.2M42.1M275.1M
Year Ago Sales206k155k30.34M38.35M
Sales Growth (year/est)7,497.10%27,590.30%26.40%238.90%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.85-0.87-0.98-0.83
EPS Actual-0.96-1.09-0.71-0.67
Difference-0.11-0.220.270.16
Surprise %-12.90%-25.30%27.60%19.30%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.68-0.33-3.15-1.87
7 Days Ago-0.68-0.33-3.15-1.87
30 Days Ago-0.84-0.6-3.49-2.47
60 Days Ago-0.82-0.7-3.46-2.51
90 Days Ago-0.81-0.63-3.45-2.5
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days8286
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesKPTIIndustrySectorS&P 500
Current Qtr.29.20%N/AN/A0.02
Next Qtr.69.70%N/AN/A0.06
Current Year-0.30%N/AN/A-0.03
Next Year40.60%N/AN/A0.14
Next 5 Years (per annum)-30.30%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A